UBS Group AG - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 44 filers reported holding DESIGN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$42,631
-72.0%
18,064
-25.2%
0.00%
Q2 2023$152,221
+12702.4%
24,162
+11629.1%
0.00%
Q1 2023$1,189
-99.9%
206
-99.9%
0.00%
-100.0%
Q4 2022$1,600,837
+9905.2%
156,027
+15534.0%
0.00%
Q1 2022$16,000
+1500.0%
998
+2751.4%
0.00%
Q4 2021$1,000
-94.1%
35
-96.9%
0.00%
Q3 2021$17,000
+70.0%
1,134
+127.7%
0.00%
Q2 2021$10,000
+11.1%
498
+66.0%
0.00%
Q1 2021$9,0003000.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders